Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
New England Journal of MedicinePublished 16 September 1999
Christian Torp‐Pedersen, Mogens Møller, Poul Erik Bloch-Thomsen, Lars Køber, Erik Sandøe, Kenneth Egstrup
Citations1,014
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure.
Abstract
In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure. Dofetilide had no effect on mortality.
Keywords
Medicine
The Nephron journals/Nephron journalsPrediction of Creatinine Clearance from Serum Creatinine
15,393 Citations2008Donald W. Cockcroft, Henry Gault
A formula has been developed to predict Creatinine clearance from serum creatinine (Scr) in adult males: Ccr = (140 – age) (wt kg)/72 × Scr (mg/100ml) (15% less i).
Journal of the American Society of EchocardiographyRecommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
8,141 Citations1989Nelson B. Schiller, Pravin M. Shah +10 more
New England Journal of MedicineMortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
3,252 Citations1991Debra S. Echt, Philip R. Liebson +10 more
There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
New England Journal of MedicineA Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1,776 Citations1995Lars Køber, Christian Torp‐Pedersen +11 more
Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mortality from cardiovascular causes, sudden death, and the development of severe heart failure.
The LancetEffect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
1,358 Citations1996Albert L. Waldo, A. John Camm +8 more
The prophylactic use of a specific potassium-channel blocker does not reduce mortality, and may be associated with increased mortality in high-risk patients after myocardial infarction.
New England Journal of MedicineAmiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
1,233 Citations1995Steven Singh, Ross D. Fletcher +7 more
Although amiodarone was effective in suppressing ventricular arrhythmias and improving ventricular function, it did not reduce the incidence of sudden death or prolong survival among patients with heart failure, except for a trend toward reduced mortality among those with nonischemic cardiomyopathy.
The LancetRandomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
1,110 Citations1997D G Julian, AJ Camm +5 more
The findings do not support the systematic prophylactic use of amiodarone in all patients with depressed left-ventricular function after myocardial infarction, but the lack of proarrhythmia and the reduction in arrhythmic death support the use of the drug in patients for whom antiarrhythmmic therapy is indicated.
CirculationEfficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
956 Citations1990Sharon E. Coplen, Elliott M. Antman +3 more
Quinidine treatment is more effective than no antiarrhythmic therapy in suppressing recurrences of atrial fibrillation but appears to be associated with increased total mortality.
The LancetRandomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
955 Citations1997John A. Cairns, Stuart J. Connolly +2 more
Amiodarone reduces the incidence of ventricular fibrillation or arrhythmic death among survivors of acute myocardial infarction with frequent or repetitive VPDs and the absolute-risk reductions were greatest among patients with congestive heart failure or a history of myocardia infarctions.
The LancetRandomised trial of low-dose amiodarone in severe congestive heart failure
924 Citations1994H. Doval, DanielR Nul +4 more
Low-dose amiodarone proved to be an effective and reliable treatment, reducing mortality and hospital admission in patients with severe heart failure independently of the presence of complex ventricular arrhythmias.
Journal of the American College of CardiologyAntiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
637 Citations1992Greg C. Flaker, Joseph L. Blackshear +4 more
The data suggest that in patients with atrial fibrillation and a history of congestive heart failure, the risk of antiarrhythmic drug therapy may outweigh the potential benefit of maintaining sinus rhythm.
CirculationPrognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.
580 Citations1991Holly R. Middlekauff, W. Stevenson +1 more
CirculationSpontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation
513 Citations1998Prakash Deedwania, Bramah N. Singh +4 more
In patients with CHF, amiodarone has a significant potential to spontaneously convert patients in AF to sinus rhythm, with patients who convert having a lower mortality rate than those who do not, and the drug prevented the development of new-onset AF and significantly reduced the VR in those with persistent AF.
Annals of Internal MedicinePredictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
478 Citations1992The Stroke Prevention in Atrial Fibrillation Investigators
Patients with atrial fibrillation at high risk and low risk for thromboembolism can be identified by readily available clinical variables by multivariate analysis.
Journal of the American College of CardiologyAdverse Effects of Low Dose Amiodarone: A Meta-Analysis
421 Citations1997V.R. Vorperian, Thomas C. Havighurst +2 more
Exposure to amiodarone in this dose range, for a minimal duration of 12 months, resulted in odds similar to those of placebo for hepatic and gastrointestinal adverse effects, but in significantly higher odds than those of Placebo for experiencing thyroid adverse effects.
Journal of Pharmacology and Experimental TherapeuticsVoltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.
323 Citations1992Edward Carmeliet
It is concluded that dofetilide is an efficient blocker of the fast component of ik, which is greater at more depolarized levels, recovery is slower at more hyperpolarization levels, and the block, as well as recovery, are voltage and time dependent.
The American Journal of CardiologyClassification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (The Cardiac Arrhythmia Pilot Study)
215 Citations1989H.Leon Greene, D. C. Richardson +9 more
The Cardiac Arrhythmia Pilot Study tested the feasibility of performing a larger study to determine if suppression of ventricular ectopic activity after acute myocardial infarction could improve survival.
Journal of Pharmacology and Experimental TherapeuticsUK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
189 Citations1990Michael Gwilt, John Arrowsmith +5 more
UK-68,798 is therefore a highly selective K+ channel blocking agent with class III antiarrhythmic properties, a profile that holds considerable promise for the therapy of life-threatening cardiac arrhythmias.
European Heart JournalAn echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study)
149 Citations1994Lars Køber, Christian Torp‐Pedersen +3 more
It was showed that 93% of the 7001 screened MIs had an assessable echocardiogram, and it was shown that the one-year mortality was inversely related to WMI, being 60%, 30%, 14% and 11% in patients with a WMI < 0.8.
The American Journal of CardiologyMortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.
147 Citations1998Craig M. Pratt, A. John Camm +8 more
The findings suggest that most of the d-sotalol-associated risk was in patients remote from MI with a LVEF of 31% to 40%; comparable placebo patients had a very low mortality; and very little objective data supports torsades de pointes or any specific proarrhythmic mechanism as an explanation for d- sotaloli-associated mortality risk.
The Journal of Clinical PharmacologyPharmacology and Pharmacokinetics of Amiodarone
144 Citations1991Michael D. Freedman, John C. Somberg
A pharmacokinetically based loading scheme is described, and data suggesting a role for routine amiodarone plasma levels are presented, suggesting some of the unique pharmacologic as well as toxicologic effects of the drug.
Clinical CardiologyDofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studies
106 Citations1997M Mosller
This data indicates that prolonged life with antiarrhythmic drugs in patients at increased risk of sudden cardiac death has so far been disappointing or inconclusive.
HeartAtrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients
100 Citations1997Karel Pardaens, Johan Van Cleemput +2 more
Atrial fibrillation is associated with a 20% lower peak V˙O2 in patients with chronic heart failure, suggesting that preserved atrial contraction or a regular rhythm, or both, are critical to maintain cardiac output and exercise performance.
CHEST JournalSuperiority of Oral Verapamil Therapy to Digoxin in Treatment of Chronic Atrial Fibrillation
95 Citations1983Roberto M. Lang, Herman O. Klein +7 more
Verapamil is an important and safe modality of treatment in the long-term control of heart rate in chronic atrial fibrillation and is superior to digoxin in controlling the ventricular rate and in improving exercise capacity.
The American Journal of CardiologyClinical Characteristics and Mortality of Patients Screened for Entry Into the Trandolapril Cardiac Evaluation (TRACE) Study
77 Citations1995Lars Køber, Christian Torp‐Pedersen
Care should be taken in extrapolating the result of the TRACE study to the general population with reduced LV function after AMI since the group excluded from the study had a higher mortality than those who were included.
American Heart JournalEffect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine pilot study of sudden death and amiodarone (EPAMSA)
75 Citations1995Jorge Garguichevich, JoséL. Ramos +7 more
The efficiency of prophylactic antiarrhythmic treatment with amiodarone in reducing 1-year mortality in patients with reduced left ventricular ejection fraction and asymptomatic ventricular arrhythmias was investigated in a prospective, multicenter, randomized, controlled study.
Pacing and Clinical ElectrophysiologyA Nonfluoroscopic Catheter‐Based Mapping Technique to Ablate Focal Ventricular Tachycardia
64 Citations1998Koonlawee Nademanee, Erol M. Kosar
The CARTO system is useful in mapping and guiding the ablation of focal tachycardia and merits further study.
The American Journal of CardiologyClinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris
63 Citations1992Martin L. Sedgwick, Henrik Rasmussen +1 more
The selective prolongation of the refractory periods in both atrium and ventricle, combined with a lack of effect on cardiac conduction parameters, indicates that this drug could be useful in the treatment of both atrial and ventricular reentrant tachyarrhythmias and fibrillation.
The American Journal of CardiologyLeft ventricular function in patients with atrial fibrillation before and after cardioversion
63 Citations1992Mahbubul Alam, Curt Thorstrand
The mechanical activity of the left atrium and its effect on left ventricular (LV) function after electrocardioversion of AF to sinus rhythm was evaluated using echocardiography and Doppler.
The American Journal of CardiologyFrequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy
59 Citations1992Carlo Vigna, Aldo Russo +7 more
Systemic emboli occur in dilated cardiomyopathy (DC) at an annual rate of about 4%.
European Heart JournalChrome congestive heart failure
40 Citations1994Lars Køber, Christian Torp‐Pedersen +3 more